Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (1): 60-61.
• Orignal Article • Previous Articles Next Articles
Received:2017-02-16
Revised:2017-02-16
Online:2017-01-20
Published:2017-02-16
Contact:
孙庆敏,男,硕士,主管药师,临床药学。E-mail：sunqingminnjmu@163.com
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
| [1] 李铭新,刘玲,薛俊,等.尿毒症患者甲状旁腺全切除加前臂移植术后钙的补充[J].中国血液净化, 2011, 10(3):140-153. [2] 卫生部.药品不良反应报告和监测管理办法[EB/OL].(2011-05-04)[2016-06-11] http://www.sda.gov.cn/WS01/CL0053/62621.html,. [3] Meek S E,Nix K.Hypocalcemia after alendronate therapy in a patient with celiac disease[J].Endocr Pract, 2007,13(4):403-407. [4] Naim M,Maalouf1,Howard J,et al.Bisphosphonate induced Hypocalcemia:report of 3 cases and review of literature[J].Endocrine Practice, 2006, 12(1):48-53. [5] 赵祥波,张喆弊,晏秀祥,等.双酸盐类药物研究及应用进展[J].中国骨质疏松杂志, 2011, 17(10):917-921. [6] Morelli S,Bilbao P S,Katz S,et al.Protein phosphatases: possible bisphosphonate binding sites mediating stimulation of osteoblast proliferation[J].Arch Biochem Biophys, 2011, 507(2):248-53. [7] Panzavolta S,Torricelli P,Bracci B,et a1.Alendronate and pamidronate calcium phosphate bone cements:setting properties and in vitro response of osteoblast and osteoclast cells[J].J Inorg Biochem, 2009,103(1):101-106. [8] Kanatani M,Sugimoto T,Kano J,et al.IGF-1 mediates the stimulatory effect of high phosphate concentration on osteoblastic cell proliferation[J]. Cell Physiol, 2002, 190(3):306-312. [9] 吴宗键,王继芳,卢世璧,等.阿伦磷酸钠对人成骨细胞增殖的影响[J].中国矫形外科杂志, 2002, 5(9):464-466. [10] Biswas P N,Wilton L V,Shakir S A.Pharmacovigilance study of alendronate in England[J].Osteoporos Int,2003,14(6):507-514. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
